药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tetracosactide
Halometasone
The risk or severity of hyperglycemia can be increased when Halometasone is combined with Linagliptin.
Tetracosactide
Melengestrol
The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Melengestrol.
Tetracosactide
Fluprednisolone
The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Fluprednisolone.
Tetracosactide
Fluticasone
The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Fluticasone.
Tetracosactide
Fluticasone furoate
The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Fluticasone furoate.
Tetracosactide
Mometasone furoate
The risk or severity of hyperglycemia can be increased when Mometasone furoate is combined with Linagliptin.
Tetracosactide
Cloprednol
The risk or severity of hyperglycemia can be increased when Cloprednol is combined with Linagliptin.
Tetracosactide
Prednylidene
The risk or severity of hyperglycemia can be increased when Prednylidene is combined with Linagliptin.
Tetracosactide
Cortivazol
The risk or severity of hyperglycemia can be increased when Cortivazol is combined with Linagliptin.
Tetracosactide
Clobetasol
The risk or severity of hyperglycemia can be increased when Clobetasol is combined with Linagliptin.
Tetracosactide
Dexamethasone isonicotinate
The risk or severity of hyperglycemia can be increased when Dexamethasone isonicotinate is combined with Linagliptin.
Tetracosactide
Meprednisone
The risk or severity of hyperglycemia can be increased when Meprednisone is combined with Linagliptin.
Tetracosactide
Fluocortolone
The risk or severity of hyperglycemia can be increased when Fluocortolone is combined with Linagliptin.
Tetracosactide
Fluprednidene
The risk or severity of hyperglycemia can be increased when Fluprednidene is combined with Linagliptin.
Tetracosactide
Ciclesonide
The risk or severity of hyperglycemia can be increased when Ciclesonide is combined with Linagliptin.
Tetracosactide
Paramethasone
The risk or severity of hyperglycemia can be increased when Paramethasone is combined with Linagliptin.
Tetracosactide
Cortisone acetate
The risk or severity of hyperglycemia can be increased when Cortisone acetate is combined with Linagliptin.
Tetracosactide
Corticotropin
The risk or severity of hyperglycemia can be increased when Corticotropin is combined with Linagliptin.
Tetracosactide
Elexacaftor
The serum concentration of Elexacaftor can be increased when it is combined with Linagliptin.
Tetracosactide
Lasmiditan
The serum concentration of Linagliptin can be increased when it is combined with Lasmiditan.